Davies acted for Monsanto Company with respect to Canadian regulatory matters in its approximately US$63 billion acquisition by Bayer AG.
The merger, which will form a global leader in agriculture, faced extensive regulatory reviews internationally and in Canada. To address concerns about the competitive impact of the proposed transaction in Canada, the Commissioner of Competition and Bayer AG entered into a Consent Agreement requiring Bayer to divest its canola seeds and traits business, as well as its soybean seeds and traits business, its carrot seeds business and a seed treatment business.
Davies’ Competition, Antitrust & Foreign Investment team is frequently retained to provide its expertise in the most complex and high-profile Canadian and multinational mergers. The team on this transaction included John Bodrug, Elisa Kearney and Alysha Manji-Knight.
Disclosure Interrupted: CSA Pauses Climate and Diversity Disclosure Rules
Apr. 28, 2025 - The Canadian Securities Administrators (CSA) is pausing its work on climate-related and diversity-related disclosure rules in order “to support Canadian markets and issuers as they adapt to the recent developments in the U.S. and globally. ” Consistent with the CSA’s recent regulatory shift...
Canada Updates National Security Review Guidelines Amid Trade Tensions
Mar. 06, 2025 - Canada’s Minister of Innovation, Science and Industry (Minister), François-Philippe Champagne, has announced an update to the Investment Canada Act (ICA) National Security Review Guidelines (Guidelines) to expressly include “the potential of the investment to undermine Canada’s economic...
